Is Lemborexant currently available in the country and the formal purchasing channels?

Lemborexant () is a dual orecktan receptor antagonist (DORA), mainly used to treat adult insomnia patients who have difficulty falling asleep or maintaining sleep. The drug improves sleep quality and prolongs total sleep time by selectively blocking the orexin receptors involved in sleep-wake regulation. In 2019, the original drug Leborexan was launched in the United States under the trade name Dayvigo and received clinical approval.

At present, the original drug of Leborexan has been officially launched in the country, but it has not yet been included in the medical insurance system. This means that if domestic patients need to use the drug, they need to bear the entire cost of the drug. The prices of domestically marketed drugs are relatively high, but they can be purchased legally through regular hospitals or designated pharmacies to ensure drug quality and medication safety. Patients should avoid purchasing through informal channels to prevent counterfeit or low-quality medicines.

In overseas markets, the price of the Japanese version of Lebrasin’s original drug is about RMB 1,000. So far, generic drugs of Leborexan have not yet been launched on the market. No matter in the domestic or foreign markets, patients can only choose the original drug for treatment. This also requires patients to pay attention to formal channels and customs laws and regulations when obtaining drugs to ensure the safety of drug transportation and use.

To sum up, the original drug Lebrasin can be purchased through formal channels in China, but it has not yet been included in medical insurance, and patients need to pay for it themselves. The price of Japanese original drugs in overseas markets is relatively stable, while generic drugs are not yet available. When choosing a purchasing channel, patients should combine their own economic status and clinical medication needs, obtain drugs through legal and safe channels, and use them under the guidance of doctors to ensure efficacy and medication safety.

Reference link:https://www.drugs.com